Publications 21 Datasets 392.5k Experiments 4.7k

Explore

21 matching publication(s)

Publication	Journal	Year	Score	Verdict
Advances in genomic and pharmacokinetic profiling for clinical stratification of metastatic breast cancer. PMID 41369820	Discov Oncol	2025	59	L1 59/100
Interpretable artificial intelligence based on immunoregulation-related genes predicts prognosis and immunotherapy response in lung adenocarcinoma. PMID 41048340	Front Bioinform	2025	71	L1 71/100
Multimodal data integration for biologically-relevant artificial intelligence to guide adjuvant chemotherapy in stage II colorectal cancer. PMID 40472802	EBioMedicine	2025	83	L1 83/100
Integrating multi-omics data reveals the antitumor role and clinical benefits of gamma-delta T cells in triple-negative breast cancer. PMID 40197136	BMC Cancer	2025	59	L1 59/100
IRSN-23 gene diagnosis enhances breast cancer subtype classification and predicts response to neoadjuvant chemotherapy: new validation analyses. PMID 40128415	Breast Cancer	2025	71	L1 71/100
Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSCLC: Phase 2 trial interim results (NEOTIDE/CTONG2104). PMID 38897205	Cell Rep Med	2024	72	L1 72/100
Decoding the tumor microenvironment and molecular mechanism: unraveling cervical cancer subpopulations and prognostic signatures through scRNA-Seq and bulk RNA- PMID 38482016	Front Immunol	2024	80	L1 80/100
Integrated multiomic analysis reveals disulfidptosis subtypes in glioblastoma: implications for immunotherapy, targeted therapy, and chemotherapy. PMID 38504986	Front Immunol	2024	73	L1 73/100
Machine Learning-Based Integrated Analysis of PANoptosis Patterns in Acute Myeloid Leukemia Reveals a Signature Predicting Survival and Immunotherapy. PMID 38322112	Int J Clin Pract	2024	71	L1 71/100
A novel oxidative stress-related gene signature as an indicator of prognosis and immunotherapy responses in HNSCC. PMID 38157249	Aging (Albany NY)	2023	85	L1 85/100
Assessment tool based on fatty acid metabolic signatures for predicting the prognosis and treatment response in bladder cancer. PMID 38076064	Heliyon	2023	71	L1 71/100
Application of Machine Learning in Predicting Hepatic Metastasis or Primary Site in Gastroenteropancreatic Neuroendocrine Tumors. ⚑ PMID 37887568	Curr Oncol	2023	59	L1 59/100 ⚑
A urine extracellular vesicle lncRNA classifier for high-grade prostate cancer and increased risk of progression: A multi-center study. ⚑ PMID 37852185	Cell Rep Med	2023	65	65/100 ⚑
PD-1 blockade potentiates neoadjuvant chemotherapy in NSCLC via increasing CD127+ and KLRG1+ CD8 T cells. PMID 37231145	NPJ Precis Oncol	2023	40	L1 40/100
Comprehensive analysis of mitophagy in HPV-related head and neck squamous cell carcinoma. PMID 37161060	Sci Rep	2023	73	L1 73/100
Comprehensive analysis of a novel RNA modifications-related model in the prognostic characterization, immune landscape and drug therapy of bladder cancer. PMID 37124622	Front Genet	2023	71	L1 71/100
Identifying Molecular Subtypes and 6-Gene Prognostic Signature Based on Hypoxia for Optimizing Targeted Therapies in Non-Small Cell Lung Cancer. PMID 35509605	Int J Gen Med	2022	59	L1 59/100
Molecular Biomarker of Drug Resistance Developed From Patient-Derived Organoids Predicts Survival of Colorectal Cancer Patients. PMID 35425715	Front Oncol	2022	53	L1 53/100
Developing prognostic gene panel of survival time in lung adenocarcinoma patients using machine learning. ⚑ PMID 35117753	Transl Cancer Res	2020	32	L1 32/100 ⚑
Construction and Validation of an Immune Infiltration-Related Gene Signature for the Prediction of Prognosis and Therapeutic Response in Breast Cancer. ⚑ PMID 33986754	Front Immunol	2021	51	L1 51/100 ⚑
Prediction of prognostic signatures in triple-negative breast cancer based on the differential expression analysis via NanoString nCounter immune panel. PMID 33138797	BMC Cancer	2020	72	L1 72/100